Kestra Medical plans sale of 4,117 common shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Kestra Medical Technologies, Ltd. has a proposed sale of 4,117 shares of its common stock through Merrill Lynch on NASDAQ, dated 07/30/2026. The shares relate to performance share unit awards that vested on 07/17/2026 and were granted under the issuer’s equity compensation plan.
Key Figures
Key Terms
Form 144 regulatory
equity compensation plan financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Kestra Medical Technologies (KMTS) report in this Form 144 filing?
Which broker and exchange are involved in the KMTS stock sale notice?
AI-generated analysis. How Rhea-AI works. Not financial advice.